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Abstract The ryanodine receptor/Ca2+ release channels from
skeletal (RyR1) and cardiac (RyR2) muscle cells exhibit
different inactivation profiles by cytosolic Ca2+. D3 is one of
the divergent regions between RyR1 (amino acids (aa) 1872^
1923) and RyR2 (aa 1852^1890) and may contain putative
binding site(s) for Ca2+-dependent inactivation of RyR. To test
this possibility, we have deleted the D3 region from RyR1 (vD3-
RyR1), residues 1038^3355 from RyR2 (v(1038^3355)-RyR2)
and inserted the skeletal D3 into v(1038^3355)-RyR2 to
generate sD3-RyR2. The channels formed by vD3-RyR1 and
v(1038^3355)-RyR2 are resistant to inactivation by mM [Ca2+],
whereas the chimeric sD3-RyR2 channel exhibits significant
inactivation at mM [Ca2+]. The vD3-RyR1 channel retains its
sensitivity to activation by caffeine, but is resistant to inactiva-
tion by Mg2+. The data suggest that the skeletal D3 region is
involved in the Ca2+-dependent regulation of the RyR1 channel.
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Key words: Ryanodine receptor; Excitation-contraction
coupling; Functional expression; Intracellular calcium
release; Lipid bilayer reconstitution; Confocal imaging
1. Introduction
Excitation-contraction (E-C) coupling is the process where-
by depolarization of the sarcolemma is translated into myo-
cyte contraction. This signal transduction process occurs at
the triad junction, where terminal cisternae of the sarcoplas-
mic reticulum (SR) abut the transverse tubule of the sarco-
lemma [1]. The molecular basis of E-C coupling involves the
interaction between two proteins, the SR calcium release
channel, also referred to as the ryanodine receptor (RyR),
and the voltage-gated Ca2 channel of the sarcolemma, also
known as the dihydropyridine receptor [2^4]. Three mamma-
lian isoforms of RyR have been identi¢ed. RyR1 is mainly
found in skeletal muscle [5,6], RyR2 is present in cardiac
muscle [7] and RyR3 is referred to as the brain isoform [8].
The three isoforms of RyR are remarkably similar in primary
structure, consisting of V5000 amino acids (aa) with a mem-
brane-spanning domain at the carboxyl-terminal end and a
large hydrophilic domain at the amino-terminal end [9]. The
carboxyl-terminal domain is predicted to contain 4^12 trans-
membrane segments, encompassing about one-¢fth of the pro-
tein size and is thought to form the pore of the Ca2 release
channel [10]. The amino-terminus is thought to be cytoplasmic
and constitutes the ‘foot’ region that spans the junctional gap
between the SR membrane and the transverse tubule [11].
The isolated Ca2 release channel is regulated by cytoplas-
mic Ca2 through activation and inactivation mechanisms
that are thought to occur at high- and low-a⁄nity Ca2 bind-
ing sites on the RyR protein, respectively [12]. In response to
Ca2 in the nM to WM concentration range, the Ca2 release
channel becomes activated. Higher concentrations of cytoplas-
mic Ca2 (WM to mM) lead to inactivation of the Ca2 release
channel [13,14]. One of the major di¡erences between the
skeletal and cardiac RyRs lies in the mechanism of Ca2-de-
pendent inactivation of the Ca2 release channels. The puta-
tive low-a⁄nity binding site for Ca2 has a half dissociation
constant that is about 10^20 times larger for cardiac RyR
(KDV15 mM) than that for skeletal RyR (KDV0.7 mM)
[14]. The molecular basis for this di¡erence is unclear. The
primary sequences of RyR1 and RyR2 are relatively well con-
served, but di¡er in three regions referred to as D1, D2 and
D3 [15]. The D3 region involves residues 1872^1923 of RyR1
and residues 1852^1890 of RyR2 (Fig. 1A). The D3 region of
RyR1 contains a high proportion of negatively charged aa (42
out of 52 total residues are glutamates or aspartates) and has
been hypothesized as a possible low-a⁄nity Ca2 binding site
[6]. An earlier study from our laboratory showed that a 797 aa
deletion mutant of RyR1 involving the D3 region, v(1641^
2437)-RyR1, displayed altered Ca2-dependent regulation of
the Ca2 release channel expressed in a Chinese hamster ovary
(CHO) cell line. Compared with the full-length RyR1 channel,
the v(1641^2437)-RyR1 was more resistant to inactivation by
cytoplasmic Ca2 [16].
To test the role of the D3 region of RyR in the function of
the skeletal and cardiac calcium release channels, we gener-
ated deletion mutants of RyR1 and RyR2 in which the D3
region was removed. In addition, the aa sequence 1804^1922
encoding the D3 region of RyR1 was introduced into the
RyR2 deletion mutant. The functional e¡ects of these muta-
tions were studied by expression of the proteins in CHO cells
and lipid bilayer reconstitution of single Ca2 release chan-
nels. Our results suggest that the D3 region of RyR1 exerts an
important role in Ca2-dependent regulation of the Ca2 re-
lease channel.
2. Materials and methods
2.1. Construction of RyR cDNA mutants
The entire cDNAs for RyR1 and RyR2 were cloned into the eu-
karyotic expression vectors pRRS11 and pHRRS1, respectively, with
transcription occurring under the control of the SV40 promoter [5,17].
Both expression vectors include a neomycin resistance gene, allowing
for selection of stable clones. Polymerase chain reaction (PCR)-based
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mutagenesis was utilized to generate a speci¢c deletion of the region
encoding D3 (nucleic acids 5616^5769) in pRRS11. PCR products
were generated proximal (nucleic acids 4930^5615) and distal (nucleic
acids 5770^5950) to D3 [5]. A silent single base mutation at nucleotide
5772 (G to A) was introduced in the PCR primer to generate a unique
SfuI restriction site. The two PCR products were subcloned into the
pBluescript vector and annealed at the SfuI site. The resulting frag-
ment, lacking the cDNA encoding skeletal D3, was re-introduced into
the expression vector pRRS11 to obtain the vD3-RyR1 mutant. A
deletion mutant of the cardiac RyR lacking aa 1038^3355 was gen-
erated by XbaI restriction digestion and re-annealing of pHRRS1.
The resulting vector is referred to as v(1038^3355)-RyR2. Insertion
of a PCR product encoding skeletal D3 (nucleic acids 5402^5777,
including silent mutations at both ends resulting in XbaI sites) into
v(1038^3355)-RyR2 resulted in sD3-RyR2. In addition, the cDNA
encoding vD3-RyR1 was subcloned into the mammalian expression
vector pCMS-EGFP (Clontech), resulting in pCMS-EGFP-vD3-
RyR1. pCMS-EGFP is a plasmid that constitutively expresses the
enhanced green £uorescent protein (EGFP) as a transfection marker
and the protein of interest is driven by a separate cytomegalovirus
promoter. A PCR product encoding the D3 region of RyR2 (nucleic
acids 5554^5670) was cloned into the SfuI site of pCMS-EGFP-vD3-
RyR1 to generate cD3-RyR1. All mutant constructs were con¢rmed
by restriction endonuclease digestion and sequencing.
2.2. Cell culture
CHO cells were grown in Ham’s F12 medium (Gibco BRL) en-
riched with 10% fetal bovine serum and supplemented with penicillin
(100 U/ml) and streptomycin 100 (Wg/ml) in a 5% CO2 incubator at
37‡C. Subculturing was performed using standard techniques. Cells
were harvested using a calcium-free phosphate-bu¡ered saline (PBS)
solution (containing in mM: NaCl 136.8, KCl 2.68, Na2HPO4 8.1,
KH2PO4 1.47 and EDTA 0.357). Full-length and mutant RyR pro-
teins were expressed in CHO cells using liposome-based methods
[10,16]. Transfected CHO cells were exposed to 0.5 mg/ml G418
and selected for stable transfectant clones. Expression of the RyR
proteins was determined by Western blotting, measurement of caf-
feine-induced Ca2 release in single CHO cells and lipid bilayer re-
constitution of single Ca2 release channels.
2.3. Immunocytochemistry and Western blot of RyR expression in
CHO cells
CHO cells stably expressing RyR were grown on cover slips and
¢xed in methanol at 320‡C for 1 h, using a modi¢ed procedure from
Takekura et al. [18]. The cells were treated with 5% goat serum in PBS
for 1 h to block non-speci¢c antibody binding, followed by incubation
with the anti-RyR antibodies [19,20] for 2 h and the cells were then
exposed to a Texas red-conjugated secondary antibody for 1 h. The
cells were examined on a Carl-Zeiss 410 confocal microscope, using an
excitation wavelength of 568 nm and an emission wavelength of 590
nm. Expression of the various RyR mutants in CHO cells was further
quanti¢ed using Western blot analyses, as described previously
[10,16].
2.4. In vivo assay of RyR function
Transfected CHO cells expressing wild-type (wt-) RyR1, vD3-
Fig. 1. Expression of RyR proteins in CHO cells. A: Sequence alignment of the D3 region of RyR1 and RyR2. B: Western blot of RyR ex-
pressed in CHO cells. Microsomal membrane vesicles from CHO cells expressing wt-RyR1 (lane 2), vD3-RyR1 (lane 3), v(1038^3355)-RyR2
(lane 4), sD3-RyR2 (lane 5) and cD3-RyR1 (lane 6) were loaded onto a 3^12% linear sodium dodecyl sulfate-polyacrylamide gel. The RyR pro-
teins were probed with a polyclonal antibody (rabbit 46) raised against a conserved 15 aa residues segment of the carboxyl-terminal portion of
RyR (aa 5023^5037 of RyR1). Lane 1 was loaded with microsomal membrane vesicles isolated from the untransfected CHO cells. Except for
sD3-RyR2, all other RyR constructs were stably expressed in CHO cells. C: PCR analyses of CHO cells expressing wt-RyR1 and vD3-RyR1.
A 502 bp cDNA fragment was ampli¢ed from the genomic DNA of CHO cells expressing wt-RyR1, whereas a PCR product of 346 bp was
ampli¢ed from CHO cells expressing vD3-RyR1. The reduced size re£ects the deletion of 156 bp corresponding to the D3 region. D: Immu-
nostaining of untransfected CHO cells (1) and CHO cells stably expressing wt-RyR1 (2), vD3-RyR1 (3) and v(1038^3355)-RyR2 (4) using
Texas red as a conjugate marker. Perinuclear staining consistent with ER distribution of transfected RyR is observed in 100% of the cells but
in none of the control untransfected CHO cells. The control CHO cells and those expressing wt-RyR1 and vD3-RyR1 were blotted with the
monoclonal antibody 34C. The polyclonal rabbit 46 antibody was used to immunoblot v(1038^3355)-RyR2, resulting in a weaker signal than
34C.
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RyR1, v(1038^3355)-RyR2 and sD3-RyR2 were grown in 35 mm
dishes and serum-depleted overnight. Cells were then loaded with
2 WM Fura-2-AM for 30 min at 37‡C, in a balanced salt solution
(containing in mM: NaCl 140, KCl 2.8, CaCl2 2, MgCl2 2, glucose
12, HEPES 10 and BSA 0.1%, pH 7.2). Using a dual-wavelength
spectro£uorometer, with excitation wavelength of 340 and 380 nm
and emission at 510 nm, £uorescence measurements were performed
at 37‡C in a temperature-regulated chamber, mounted on the stage of
an inverted £uorescence microscope (Olympus IX-70). Cells were ex-
posed to 10 mM ca¡eine (in Ca2-free solution) by rapid solution
exchange. Fura-2 £uorescence signals were continuously monitored
at a sampling frequency of 40 Hz and collected using the Felix soft-
ware (Photon Technology) [21].
2.5. Reconstitution of RyR channels in planar lipid bilayer
A mixture of phosphatidylethanolamine:phosphatidylserine:choles-
terol (6:6:1 ratio), dissolved in decane at a concentration of 40 mg/ml,
was used to form lipid bilayer membranes across an aperture V200
Wm diameter, separating the cis side from the trans side. CHO cells
stably or transiently expressing the di¡erent RyR mutants were har-
vested and microsomal membrane vesicles were prepared as described
previously [16]. Membrane vesicles containing the di¡erent RyR mu-
tant channels were added to the cis solution and allowed to fuse with
the bilayer under a concentration gradient of 200 mM/50 mM Cs-
gluconate (cis/trans). In addition to Cs-gluconate, both cis and trans
solutions included 1 mM CaCl2, 1 mM Cs2EGTA and 10 mM
HEPES (pH 7.4). The free ionic Ca2 concentration was measured
using a Ca2-sensitive electrode (Orion, Model 93-20, Boston, MA,
USA) and the values reported are those of free [Ca2] only. The
numbers between parentheses represent the amounts of CaCl2 (in
mM) that were added to the cis chamber to achieve the following
free Ca2 concentrations in mM: 1.0 (5.0), 5.7 (21), 10.0 (33) and
20.1 (57). Channel fusion was facilitated by applying positive voltage
and the addition of Ca2 in the cis solution to a ¢nal free concen-
tration of 220 WM. Channel recordings were performed under sym-
metrical conditions of 200 mM Cs-gluconate.
2.6. Analysis of single channel data
Single channel data were measured using an Axopatch 200A am-
pli¢er patch-clamp unit in combination with a Digidata 1200 A/D-D/
A conversion board (Axon Instruments, Foster City, CA, USA) and a
Pentium II computer. The bilayer membrane was either held at a
particular test potential and channel activity recorded or kept at
0 mV and pulsed to di¡erent test potentials, 0.5^1 s in duration.
The currents were sampled at 0.2 ms/point and ¢ltered through an
eight-pole Bessel ¢lter at 1 kHz. The analysis of single channel data
was performed using the pClamp7 program and Sigma plot software.
The open probability (Po) was calculated with respect only to the fully
open state of the channel. The total number of experiments was 74
for v(1038^3355)-RyR2 (n = 11 vesicle preparations), 97 for sD3-
RyR2 (n = 12 vesicle preparations), 242 for vD3-RyR1 (n = 19 vesicle
preparations) and 16 for cD3-RyR1 (n = 3 vesicle preparations).
3. Results
3.1. Expression of RyR in CHO cells
CHO cells were transfected with cDNAs encoding the wt-
RyR1, vD3-RyR1, v(1038^3355)-RyR2, sD3-RyR2 or cD3-
RyR1, using liposome-based gene transfection methods. Tran-
siently transfected CHO cells, or single clones of CHO cells
that permanently express the di¡erent RyR mutants (follow-
ing selection with G418), were identi¢ed by Western blot anal-
ysis. As shown in Fig. 1B, the CHO cells stably transfected
with wt-RyR1 (lane 2) expressed high molecular weight pro-
teins (V560 kDa), identical to the native RyR from the SR
membranes of skeletal muscle. The molecular weights of sta-
bly expressed vD3-RyR1 (lane 3) and transiently expressed
cD3-RyR1 (lane 6) are slightly smaller than that of the wt-
RyR1. The stably expressed v(1038^3355)-RyR2 (lane 4) and
transiently expressed sD3-RyR2 (lane 5) proteins had molec-
ular weights of V300 kDa and V320 kDa, as expected for
their respective deletions. The stable expression of vD3-RyR1
in CHO cells was con¢rmed by PCR analysis of the genomic
DNA (Fig. 1C).
The subcellular localization of wt-RyR1, vD3-RyR1 and
v(1038^3355)-RyR2 stably expressed in CHO cells was exam-
ined using immunocytochemistry and confocal microscopy.
As shown in Fig. 1D, all three constructs exhibited a perinu-
clear distribution consistent with the endoplasmic reticulum
(ER) membrane localization of the RyR proteins [22].
3.2. In vivo and in vitro assays of RyR expressed in CHO cells
We have shown previously that the cells expressing either
wt-RyR1 or wt-RyR2 can release intracellular Ca2 in re-
sponse to stimulation with ca¡eine [22,23]. To assay the in
vivo function of these RyR mutants, transfected CHO cells
were loaded with Fura-2 and Ca2 release from the ER was
measured in single CHO cells in response to stimulation with
10 mM ca¡eine. As shown in Fig. 2A, ca¡eine triggered rapid
release of Ca2 from the ER membrane in cells expressing wt-
RyR1, vD3-RyR1 and cD3-RyR1 but there was no response
in cells expressing v(1038^3355)-RyR2 or sD3-RyR2. The
lack of ca¡eine-induced Ca2 release is not due to depletion
of Ca2 from the ER, since application of ATP (0.1 mM) led
to rapid intracellular Ca2 release in all transfected cells, in-
cluding v(1038^3355)-RyR2 and sD3-RyR2. ATP binds to
purinergic receptors at the cell membrane leading to genera-
tion of IP3 and subsequent activation of the IP3 receptor [24].
Thus, deletion of D3 from RyR1 maintains the ca¡eine-de-
pendent activation of the RyR1 channel, but a larger deletion
of the cytoplasmic domain of RyR2 (aa 1038^3355) eliminates
the ca¡eine-dependent activation of RyR2.
To study the functional activity of single RyR channels,
microsomal membrane vesicles were prepared from CHO cells
expressing the various RyR proteins. Fusion of these vesicles
with the lipid bilayer resulted in incorporation of functional
Ca2 release channels. To facilitate identi¢cation of the Ca2
release channels, we used Cs-gluconate as the current-carrying
ion in the recording solution. The use of Cs as current carrier
allows for bu¡ering of the free [Ca2] to any desired level. In
addition, Cs eliminates most of the potassium channel activ-
ities present in the microsomal membrane vesicles and the
large anion gluconate does not permeate through the endog-
enous chloride channels present in the ER membranes of
CHO cells. All mutant RyR proteins formed functional chan-
nels with fast transitions between conductance states in sym-
metric 200 mM Cs-gluconate (Fig. 2). Opening of these chan-
nels required the presence of WM concentrations of cytosolic
Ca2 and application of ryanodine (5^40 WM) resulted in the
appearance of long subconductance states, characteristic of a
ryanodine e¡ect on the Ca2 release channels (not shown).
3.3. Ca2+-dependent regulation of wt-RyR1 and vD3-RyR1
channels
Similar to the wt-RyR1 channel, the vD3-RyR1 channel
exhibits fast transitions between open and closed states in
200 mM Cs-gluconate. Opening of both wt-RyR1 and vD3-
RyR1 channels requires the presence of WM [Ca2] in the
cytosolic solution, as chelation of the free Ca2 to nM con-
centrations results in complete closure of both channels (Fig.
3A). A striking di¡erence between the vD3-RyR1 and wt-
RyR1 channels is observed, however, when the cytoplasmic
[Ca2] is increased to mM concentrations. The wt-RyR1 chan-
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nel displays near complete inactivation at [Ca2] V5.7 mM,
but in contrast, the open probability (Po) of the vD3-RyR1
channel does not appear to decrease when the cytosolic [Ca2]
is increased as high as 20 mM (Fig. 3A). To analyze the Po as
a function of [Ca2], the cytoplasmic [Ca2] was changed by
adding CaCl2 or EGTA and the Ca2 inactivation and acti-
vation curves were respectively obtained. Compared to wt-
RyR1, the Ca2 inactivation curve for vD3-RyR1 is markedly
shifted to the right. The peak Po for vD3-RyR1 is observed at
2.31 mM Ca2 (0.237 þ 0.074). In contrast, the wt-RyR1 Po is
maximal (0.187 þ 0.032) at 220 WM Ca2 and decreases stead-
ily afterwards (Fig. 3C). At [Ca2] = 20.1 mM, the Po of vD3-
RyR1 (0.138 þ 0.019) is similar to that obtained at 220 WM
Ca2 (0.136 þ 0.017), whereas the wt-RyR1 channel is all but
completely closed (Po = 0.001 þ 0.001). These results are sim-
ilar to our previous study with v(1641^2437)-RyR1 [16]. Of
note, wt-RyR1 displays a higher Po at 1 mM Ca2 compared
to native RyR1 [14]. This may be related to the absence of
muscle-speci¢c accessory proteins in the CHO cells [16].
Interestingly, the Ca2 activation curve of the vD3-RyR1
channel is shifted to the left, compared to wt-RyR1, re£ecting
an increased sensitivity of the Ca2 release channel to nM
Fig. 2. Ca¡eine-induced Ca2 release and single channel recordings of RyR expressed in CHO cells. A: Ca¡eine-induced Ca2 release from
CHO cells expressing RyR proteins. The recorded increases in intracellular Ca2 (measured with the 340/380 £uorescence ratio of Fura-2) were
acquired from single CHO cells following stimulation with 10 mM ca¡eine, in the absence of extracellular Ca2. Cells expressing wt-RyR1 (a),
vD3-RyR1 (b) and cD3-RyR1 (e) exhibit rapid Ca2 release in response to ca¡eine, whereas those stably expressing v(1038^3355)-RyR2 (d)
and those transiently expressing sD3-RyR2 (e) do not support ca¡eine-induced Ca2 release. All cell types maintain intact ER Ca2 pools, as
revealed by the similar responses to ATP-induced Ca2 release. The traces are representatives of over six other cells tested for each preparation.
B: Representative single channel currents through the di¡erent RyR mutants were recorded at +50 mV test potential with 200 mM symmetric
Cs-gluconate as the current carrier, in the presence of 220 WM Ca2 in the cytosolic solution.
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[Ca2] (Fig. 3B). This contrasts with the rightward shift of the
activation curve of v(1641^2437)-RyR1 [16]. Although we do
not know the exact reason for this discrepancy, it probably
stems from a di¡erent conformational change imparted by a
deletion of 797 residues of the amino-terminal domain of
RyR1 (v(1641^2437)-RyR1) vs. a deletion of only 52 residues
(vD3-RyR1). Similar to v(1641^2437)-RyR1 [16], the vD3-
RyR1 channel exhibits inward recti¢cation at positive voltages
(not shown). Thus, in our recordings (+50 mV), the unitary
currents through vD3-RyR1 channels are about 20% smaller
than those recorded through wt-RyR1.
3.4. Ca2+-dependent regulation of v(1038^3355)-RyR2 and
sD3-RyR2 channels
In preliminary studies with the full-length RyR2 expressed
in CHO cells, we observed a dose-dependent, and complete,
inactivation of the wt-RyR2 channel by cytosolic Ca2. Com-
pared with the wt-RyR1 channel, the Ca2-dependent inacti-
vation of the wt-RyR2 channel was shifted to the right. But
the di¡erence between the recombinant wt-RyR1 and wt-
RyR2 channels was signi¢cantly less than that observed
with the native Ca2 release channels from skeletal and car-
diac muscles [14]. This likely re£ects the role of accessory
proteins in the overall function of the Ca2 release channels.
To study the potential role of the D3 region in the inactiva-
tion property of the Ca2 release channel, a clear phenotype
was needed, one that does not inactivate in response to high
[Ca2]. Based on our experience with skeletal RyR-C [10], a
large ‘foot’ region deletion was undertaken in RyR2 (v(1038^
3355)-RyR2), with the aim of obtaining a functional channel
that does not inactivate in response to high [Ca2]. sD3-RyR2
was generated to study the role of skeletal D3 in the Ca2-
dependent regulation of RyR.
Despite deletion of a large portion of the cytosolic domain
of RyR2, both v(1038^3355)-RyR2 and sD3-RyR2 channels
still retain the Ca2 activation characteristic of RyR and are
sensitive to modulation by ryanodine (not shown). However,
compared with the wt-RyR2 channel, the open probabilities
of v(1038^3355)-RyR2 and sD3-RyR2 channels are signi¢-
cantly higher and the mutant channels exhibit altered conduc-
tance patterns [23]. At 220 WM Ca2, the average Po for wt-
RyR2 was 0.215 þ 0.035, 0.542 þ 0.102 for v(1038^3355)-
RyR2 and 0.543 þ 0.052 for sD3-RyR2. To compare the
Ca2-dependent inactivation of the v(1038^3355)-RyR2 and
sD3-RyR2 channels, the cytosolic [Ca2] was increased from
WM up to mM concentrations. As shown in Fig. 4A, the
v(1038^3355)-RyR2 channel does not display apparent inac-
tivation at mM [Ca2]. In contrast, the sD3-RyR2 channel
does exhibit signi¢cant inactivation under similar conditions
of elevated cis [Ca2] (Fig. 4B). Thus, deletion of aa 1038^
3355 from RyR2 completely eliminates Ca2-dependent inac-
tivation of the RyR2 channel and insertion of skeletal D3 into
the cardiac deletion mutant v(1038^3355)-RyR2 restores
Ca2-dependent inactivation of the Ca2 release channel.
Without a clear phenotypic di¡erence between the wt-RyR1
and wt-RyR2 channels, we did not pursue functional com-
parisons between the wt-RyR2 and chimeric cardiac D3 in
RyR1.
Fig. 3. Ca2-dependent regulation of wt-RyR1 and vD3-RyR1. Representative single channel currents from wt-RyR1 and vD3-RyR1 at 220
WM (upper panels), 16 nM (middle panels) and elevated [Ca2] (bottom panels) (A). While both channel types displayed preserved Ca2 activa-
tion properties (middle panels), the vD3-RyR1 channel exhibited marked resistance to inactivation by mM [Ca2] (bottom panels). Open prob-
abilities (Po) of the wt-RyR1 (R) and vD3-RyR1 (F) channels were plotted as a function of the cytosolic [Ca2]. Each data point represents
the mean þ S.E.M. (n = 6^30). Compared with the wt-RyR1 channel, the activation curve of the vD3-RyR1 channel was shifted to the left (B)
and inactivation was shifted to the right (C).
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3.5. E¡ect of Mg2+ on the wt-RyR1 and vD3-RyR1 channels
To further test the function of the D3 region of RyR1 as a
potential low-a⁄nity Ca2 inactivation site(s), we compared
the e¡ect of Mg2 on the wt-RyR1 and vD3-RyR1 channels.
As shown in Fig. 5A, application of 30 mM MgCl2 to the
cytosolic solution resulted in complete closure of the wt-RyR1
channel, but no inhibitory e¡ect on the vD3-RyR1 channel
was observed even after addition of 60 mM MgCl2. A de-
crease in the Po and to a lesser extent of single channel con-
ductance is noted with wt-RyR1 but not with vD3-RyR1. The
lack of an e¡ect of Mg2 on the vD3-RyR1 channel (both Po
and conductance) may re£ect the altered binding a⁄nity of
the mutant channel to Mg2 or the altered permeation prop-
erties of the channel to Mg2.
The data shown in Fig. 5B demonstrate that the vD3-RyR1
channel is resistant to inhibition by Mg2. This is consistent
Fig. 4. Ca2-dependent inactivation of the v(1038^3355)RyR2 and sD3-RyR2. Selected single channel currents from v(1038^3355)-RyR2 (A)
and sD3-RyR2 (B) were obtained under the same recording conditions as shown in Fig. 2B. Increasing the cytosolic [Ca2] to 20.1 mM leads
to signi¢cant inactivation of the sD3-RyR2 channels, but no change in activity of the v(1038^3355)-RyR2 channel. The open probabilities of
the v(1038^3355)-RyR2 and sD3-RyR2 channels were calculated at +50 mV test potential, with cytosolic [Ca2] ranging from 220 WM to 20.1
mM. Each data point represents the average over 4^12 di¡erent experiments.
Fig. 5. E¡ects of Mg2 on the wt-RyR1 and vD3-RyR1 channels. The current traces from a wt-RyR1 channel (A) or a vD3-RyR1 channel
(B) were acquired at [Ca2] = 220 WM in 200 mM Cs-gluconate, at a test potential of +50 mV, in the presence of di¡erent concentrations of
MgCl2. Open probabilities (Po) of wt-RyR1 (R) and vD3-RyR1 (F) were plotted as a function of [MgCl2] added to the cis solution (C). n = 9
for vD3-RyR1 and n = 4 for wt-RyR1.
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with observations from other investigators, suggesting that
Mg2 inhibits the skeletal muscle Ca2 release channel via
interaction with a putative Ca2 inactivation domain on the
RyR1 protein [12,25].
4. Discussion
Ca2-dependent inactivation of the RyR channels plays an
important role in E-C coupling in cardiac and skeletal muscle
cells, acting as an alternative mechanism to terminate the
Ca2 release process following an action potential stimulation
[26,27]. It is well known that the skeletal and cardiac Ca2
release channels respond di¡erently to inactivation by cyto-
solic Ca2 and regions of divergence between the primary
sequences of RyR1 and RyR2 have been proposed as possible
explanatory mechanisms [16]. In this study, we show that
deletion of the D3 region from RyR1 results in functional
Ca2 release channels that are more sensitive to activation
by low cytosolic [Ca2] and markedly resistant to inactivation
by elevated cytoplasmic [Ca2]. This may re£ect loss of a
Ca2 inactivation binding site or change in the conformation
of the Ca2 release channel, resulting in resistance to modu-
lation by elevated cytosolic [Ca2]. The fact that a chimeric
mutant of RyR2, sD3-RyR2, consisting of skeletal D3 in-
serted into v(1038^3355)-RyR2, exhibits signi¢cant Ca2-de-
pendent inactivation argues strongly in favor of an active role
of the D3 region of RyR1 in the Ca2 inactivation process.
Ca2-dependent activation and inactivation of RyR occur
at spatially distinct binding sites, since mutant constructs of
RyR1 and RyR2 lacking D3 displayed resistance to inactiva-
tion by Ca2, but retained Ca2 activation properties. The
cytoplasmic domain of RyR2 appears to be important for
the function of the Ca2 release channel, as deletion of aa
1038^3355 from RyR2 a¡ected not only the Ca2-dependent
inactivation of the RyR2 channel but also the response to
ca¡eine. This is consistent with our earlier observations with
the RyR-C channel lacking aa 183^4006 of RyR1. This trun-
cated channel maintains Ca2-dependent activation but lacks
Ca2-dependent inactivation and ca¡eine-induced Ca2 re-
lease [10,22]. Furthermore, the open probabilities of the
v(1038^3355)-RyR2 and sD3-RyR2 channels are signi¢cantly
higher than those of the wt-RyR2 and wt-RyR1 channels, at
WM to low mM [Ca2]. Both deletion channels exhibit con-
ductance changes even though the deleted segments (1872^
1923 of RyR1 and 1038^3355 of RyR2) in the primary se-
quence lie distant from the putative pore [28]. This indicates
that domains in the ‘foot’ region of RyR may interact with
the carboxyl-terminal/pore region and a¡ect channel function
or alternatively, deletion of these segments could introduce
allosteric changes in the protein structure and a¡ect the over-
all permeation and regulatory properties of the Ca2 release
channel. These results, when taken together, re£ect the impor-
tance of regulatory domains of the ‘foot’ region of RyR in
modulating the Ca2 release channel activity.
The inhibition of RyR by Mg2 has been proposed to in-
volve two independent processes [12,25]. Mg2 may inhibit the
RyR channel by competing with Ca2 (type I inhibition) at
the high-a⁄nity Ca2 binding site. Alternatively, Mg2 may
bind to the low-a⁄nity Ca2 binding site, which does not
discriminate between Ca2 and Mg2, and inactivate the
Ca2 release channel (type II inhibition). The resistance to
inactivation by Mg2 of the vD3-RyR1 channel, at 220 WM
Ca2, suggests that Mg2 ions interact with the D3 region of
RyR1 to e¡ect inactivation of the Ca2 release channel (type
II inhibition). Taken together, our data indicate that the skel-
etal D3 region likely represents a putative Ca2 regulatory
domain of the RyR1 channel that is involved in Ca2- and
Mg2-dependent inactivation of the Ca2 release channel.
Du and MacLennan used a [3H]ryanodine binding assay
with chimeric constructs between RyR1 and RyR2 and con-
cluded that the Ca2 inactivation sites are located in the car-
boxyl-terminal quarter of the RyR1 protein [29]. In their stud-
ies with the detergent-solubilized RyR proteins, the full-length
RyR2 did not show apparent Ca2-dependent inactivation at
[Ca2] as high as 20 mM. But studies from other investigators
and our laboratory (unpublished data with the wt-RyR2 ex-
pressed in CHO cells) have shown that RyR2 does display
inactivation at elevated mM [Ca2] [14]. Thus, while the
[3H]ryanodine binding approach using solubilized chimeric
constructs of RyR1 and RyR2 may help to address the func-
tional di¡erence between the two proteins, a better under-
standing of the fundamental mechanism for Ca2-dependent
regulation of the Ca2 release channels requires further struc-
ture-function studies. It is possible that multiple interacting
Ca2 binding sites reside on the RyR proteins (some on the
foot region, e.g. D3 region, and some on the carboxyl-termi-
nal end) and participate in the overall regulation of the Ca2
release channel function.
In addition to its role in the Ca2-dependent regulation of
the Ca2 release channel, the D3 region of RyR1 may play an
important role in the E-C coupling process. The molecular
determinants of the E-C coupling in skeletal muscle involve
the II-III loop of the dihydropyridine receptor and as yet an
undetermined component in the ‘foot’ region of RyR1. Cyto-
plasmic regions that are divergent between RyR1 and RyR2
(i.e. D2 or D3) appear to be the most likely candidates to
interact with DHPR. Using dyspedic myotubes that lack en-
dogenous RyR1 and RyR3, Yamazawa et al. [30] demon-
strated that expression of a mutant RyR1 channel lacking
residues 1303^1406 (includes D2) abolished skeletal type E-
C coupling. However, this region alone does not determine
the functional di¡erence in E-C coupling between skeletal and
cardiac muscles, since a chimeric construct containing the cor-
responding region (D2) of RyR2 is capable of restoring skel-
etal type E-C coupling. A separate study by Nakai et al. [31]
reported that a chimeric construct consisting of residues 1635^
2636 of RyR1 (includes D3) inserted into RyR2, mediated
skeletal type E-C coupling in dyspedic myotubes and en-
hanced the Ca2 channel function of DHPR. Future studies
with D3 mutants expressed in dyspedic myotubes should pro-
vide further insights into the role of the D3 region in the E-C
coupling process of skeletal and cardiac muscle cells.
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